Intellectual Property Laws - Pharma

Relevant Publications

International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish.

Issue Release: 2024

Intellectual property law protection for energy-efficient innovation in Saudi Arabia.

Issue Release: 2024

Considerations for Clinician-Educators Developing Online Educational Content: A Narrative Review.

Issue Release: 2024

Intellectual property protection for traditional medical knowledge in China\'s context: a round peg in a square hole?

Issue Release: 2023

Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.

Issue Release: 2023

The Legal Determinants of Scarcity: Expanding Human Rights Advocacy for Affordability of Health Technologies.

Issue Release: 2023

After biosovereignty: The material transfer agreement as technology of relations.

Issue Release: 2023

Overcoming tobacco industry opposition to standardized packaging in the Americas.

Issue Release: 2022

Exploring risks of investor claims brought forth after the TRIPS waiver for COVID-19.

Issue Release: 2022

Trade, intellectual property, and the public health bearing.

Issue Release: 2022

What is the impact of intellectual property rules on access to medicines? A systematic review.

Issue Release: 2022

COVID-19 and counterfeit vaccines: Global implications, new challenges and opportunities.

Issue Release: 2022

Legal Implications of Stroke Biobanking and Genomics Research in Sub-Saharan Africa.

Issue Release: 2022

Institutional Framework for the Management of Human Genetic Resources in China.

Issue Release: 2021

A deep learning model for mass screening of COVID-19.

Issue Release: 2021

Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.

Issue Release: 2021

[The Legal Risks Faced in Nursing and Smart Healthcare].

Issue Release: 2021

Open Science for private Interests? How the Logic of Open Science Contributes to the Commercialization of Research.

Issue Release: 2020

[Conceptual map of public health and intellectual property in Cuba: 2020 updateMapa conceitual sobre saúde pública e propriedade intelectual em Cuba: atualização de 2020].

Issue Release: 2020

Making Use of Existing International Legal Mechanisms to Manage the Global Antimicrobial Commons: Identifying Legal Hooks and Institutional Mandates.

Issue Release: 2020

What are the Challenges Faced by Generic Manufacturers?

What is Patient Education in Pharma?

What are the Benefits of Collaborative Care Models?

What is Transitional Care?

Why is Geriatric Care Important?

Why Are Clinical Trials Important?

How Can ADEs be Prevented?

What is Pharmaceutical Science?

What are Collaborative Care Models?

What Causes Adverse Drug Events?

Partnered Content Networks

Relevant Topics